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A b s t r a c t
Introduction: The availability of rotational atherectomy (RA) has recently increased in Poland, which was followed by an increase 
in the rate of RA procedures and catheterization laboratories performing RA. 
Aim: To assess current trends regarding the rapid increase in the number of RA procedures and catheterization laboratories 
performing RA. 
Material an methods: We analyzed patients treated with percutaneous coronary intervention (PCI) in the years 2014–2017 
available in the nationwide ORPKI dataset. From the overall 431,467 patients treated with PCI, we extracted 1,873 treated with RA. 
We analyzed the relationship between frequency of RA usage, its distribution between low and high volume centers and procedural 
outcomes, procedural-related complications and the PCI effectiveness expressed as the target vessel patency rate after PCI.
Results: The number of RA procedures increased from 181 in 2014 (0.19%) to 698 in 2017 (0.61%), with an over two-fold in-
crease in the number of catheterization laboratories performing RA from 25 (15.5%) in 2014 to 55 (34.1%) in 2017. Besides the fact 
that patient characteristics have changed in the most recent years, the rate of procedural success expressed as procedure-related 
complications remained stable in the 3 years 2015–2017 and was around 3%, while the procedural effectiveness expressed as pat-
ent target coronary artery after PCI was stable and over 98% in all of the analyzed years. 
Conclusions: Along with the increasing number of RA procedures and catheterization laboratories performing RA in Poland, the 
procedural effectiveness remained stable during an observational period of 4 years. 
Key words: percutaneous coronary interventions, rotational atherectomy, periprocedural complications, procedural effective-
ness.
S u m m a r y
The availability of rotational atherectomy (RA) has increased recently in Poland, which was followed by an increase in the 
rate of RA procedures and catheterization laboratories (CathLabs) performing. We observed an above threefold increase in the 
number of RA procedures from 181 in 2014 (0.19%) to 698 in 2017 (0.61%) and an above two fold increase in the number of 
CathLabs performing RA from 25 (15.5%) in 2014 to 55 (34.1%) in 2017. Apart from the increase the number of RA procedures 
and CathLabs performing RA, its procedural effectiveness remains at a stable level.
Rafał Januszek et al. Trends in the use of rotational atherectomy in Poland 
159Advances in Interventional Cardiology 2019; 15, 2 (56)
Introduction
The improvement of diagnostics and treatment meth-
ods in interventional cardiology among well-developed 
countries leads to an increase in the number of patients 
with more advanced atherosclerosis and disseminat-
ed calcified lesions as potential candidates for percu-
taneous coronary interventions (PCIs) [1]. The PCI with 
rotational atherectomy (RA) could be an option for per-
cutaneous treatment of complex and calcified coronary 
artery disease. Nowadays, due to an increase in overall 
experience and availability of RA, patients are more of-
ten being transferred from cardiac bypass surgery to PCI 
and treatment with PCI, and RA could serve as a bridge 
between PCI and cardiac surgery in selected patients [2]. 
From a different point of view, it can be said that RA use 
could serve as a filter for patients with multivessel dis-
ease having severely calcified coronary artery stenoses, 
being potentially complex cases for cardiac surgery. Due 
to the fact that the reimbursement policy has changed 
in Poland in recent years, we can observe an increase in 
the rate of RA procedures and a gradual increase in the 
number of new catheterization laboratories all over the 
country [3]. It may be suspected that the currently vis-
ible decentralization of well-experienced centers in RA 
procedures could result in a change of procedure qual-
ity. The present European consensus on RA advises that 
optimal outcomes for the RA procedure are achieved by 
regular usage of this technology [4]. It is also suggested 
that it might be safer to consider transferring a patient to 
a high-volume center which is well experienced in this 
procedure [4]. Additionally, it is advised that potential ro-
tablator operators could benefit from training at high-vol-
ume centers [4]. Moreover, in some countries, physicians 
intending to perform the RA procedure have to pass 
a certification course under supervision, which should 
be signed off by the RA training directorate [4]. However, 
the above-mentioned guidelines do not precisely indi-
cate the number of annual RA procedures which have to 
be performed by a particular catheterization laboratory 
to be recognized as a high-volume center as well as the 
annual number of procedures to be performed by an ex-
perienced RA operator. 
Aim
The aim of the present study was to assess current 
trends related to RA procedures in Poland at the time of 
its rapid growth and while the number of new low-vol-
ume centers is constantly increasing. 
Material and methods
Study population, design and definitions
Data from all patients who underwent PCI in Poland 
between January 2014 and December 2017 were an-
alyzed. Prospectively collected data on PCI practice in 
Poland were obtained from the ORPKI Polish National 
dataset, which is coordinated nationwide by Jagiellonian 
University Medical College in cooperation with AISN PTK 
(Association of Cardiovascular Interventions, Polish Cardi-
ac Society). Database characteristics and data collection 
methods have been previously published [3, 5–7]. Pa-
tients were categorized according to whether they were 
treated with RA or not over a 4-year period (2014–2017). 
Additionally, we presented the number of centers that 
can perform RA and centers with the highest RA proce-
dure rate. Altogether, there are 162 centers in the data-
base for these 4 years, but individual ones do not exist 
anymore, and some have just begun their activities. There 
are no centers in Poland not collecting data in the ORPKI 
database. All indices recorded in the ORPKI database are 
based on periprocedural data uploaded by the operator 
after each procedure. Therefore, they do not include all 
in-hospital complications, mainly those occurring after 
the procedure and until discharge from the hospital. Also, 
we did not collect follow-up data after discharge due to 
lack of patient IDs. At each center, the decision to per-
form the RA procedure was at the operators’ discretion, 
according to current European recommendations [4]. All 
clinical decisions, such as vascu lar access, thrombectomy, 
and treatment with glycoprotein (GP) IIb/IIIa inhibitors or 
bivalirudin, were also the choice of the operator. The defi-
nition of periprocedural complications including death, 
perforation, dissection, allergic reaction, cerebral stroke, 
puncture-site bleeding, no-reflow, procedural-related 
myocardial infarction or cardiac arrest remained accord-
ing to the operators’ personal preferences and knowl-
edge and with regard to current European definitions [8].
Statistical analysis
Continuous variables are presented as mean ± stan-
dard deviation. Categorical variables are presented as nu-
meric values and percentages. Continuous variables were 
compared using the Kruskal-Wallis ANOVA test, whereas 
in the case of categorical variables they were compared 
using the χ2 test. Statistical significance was accepted at 
a 0.05 level of probability. Statistical analyses were per-
formed using the Statistica 10.0 software (Dell Software, 
Inc, Round Rock, TX, USA). 
Results
General trends in RA frequency and  
the number of catheterization laboratories
The number of catheterization centers performing RA 
increased from 25 (15.5%) in 2014 to 55 (34%) in 2017, 
which was statistically significant (p = 0.001). Also, the 
number of RA procedures increased in successive years 
from 181 (0.19%) in 2014 to 698 (0.61%) in 2017. Despite 
the increase in the number of catheterization centers, 
the percentage of patients undergoing RA procedures in 
high-volume centers with an RA rate greater than 10 per 
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year remained high and stable. Their value was 64.6%, 
85.6%, 83.6% and 83.7%. When the rate of RA was great-
er than 20 per year, there was a slight tendency towards 
a decrease, and this totaled 51.4%, 54.1%, 34.1% and 
46.8% in the successive years (from 2014 to 2017). The 
number of catheterization laboratories performing more 
than 20 RA procedures per year significantly increased in 
the studied period from 3 (12%) to 8 (22.2%), 5 (11.1%) 
and 10 (18.2%) in the successive years (from 2014 to 
2017). This is presented in Table I and Figure 1. 
Table I. Number of catheterization laboratories and patients in which rotational atherectomy angioplasties 
were performed in Poland between 2014–2017
Variable Years P-value
2014 2015 2016 2017
Number of cath labs performing RA 25 (15.5) 36 (22.3) 45 (27.9) 55 (34.1) 0.001
Number of cities performing RA 17 22 28 36 –
Number of patients treated with PCI and RA 181 458 536 698 –
Number of cath labs with > 10 RA/year 5 (20) 19 (52.8) 24 (53.3) 28 (51) 0.03
Number of patients in cath labs with > 10 RA/year 117 (64.6) 392 (85.6) 448 (83.6)  584 (83.7) < 0.001
Number of cath labs with > 20 RA/year 3 (12) 8 (22.2) 5 (11.1) 10 (18.2) 0.51
Number of patients in cath labs with > 20 RA/year 93 (51.4) 248 (54.1) 183 (34.1)  327 (46.8) < 0.001
Number of cath labs with > 30 RA/year 2 (8) 3 (8.3) 3 (6.7) 3 (5.4) 0.95
Number of patients in cath labs with > 30 RA/year 71 (39.2) 107 (23.4) 133 (24.8) 166 (23.8) < 0.001
Number of cath labs with > 50 RA/year 0 (0) 1 (2.8) 1 (2.2) 2 (3.6) 0.81
Number of patients in cath labs with > 50 RA/year 0 (0) 50 (10.9) 58 (10.8) 134 (19.2) < 0.001
cath lab – catheterization laboratory, PCI – percutaneous coronary intervention, RA – rotational atherectomy.
Figure 1. Number of catheterization laboratories in Poland with the rate of RA procedures more than 20 per 
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General characteristics 
The frequency of concomitant diseases in successive 
years did not differ significantly between particular years, 
with one exception for prior PCIs. Their rate was higher 
in 2016 compared to others. Nonetheless, the frequency 
of concomitant diseases tends to decrease for diabetes, 
hypertension, prior coronary artery bypass grafting op-
eration and cerebral stroke, smoking habits, and kidney 
failure, and also the mean age was lower in the most 
recent year (Table II). 
Clinical presentation, angiography and vascular 
access
The percentage of patients with stable angina sig-
nificantly increased from the year 2014 to 2017 (50.8% 
vs. 63.1%, p < 0.001), while the percentage of patients 
Table II. General characteristics, clinical presentation, vascular access and angiographic image of patients tre-
ated with rotational atherectomy in Poland between 2014–2017
Variable Years P-value
2014 2015 2016 2017
All percutaneous coronary interventions 92,425 110,912 113,848 114,282 < 0.001
Rotational atherectomy 181 (0.19) 458 (0.41) 536 (0.47) 698 (0.61)
Age [years] 72.3 (10.4) 71.8 (9.5) 71.5 (9.6)  71.4 (9.7) 0.85
Gender, male 117 (65.7) 314 (68.5) 370 (69) 482 (69) 0.85
Diabetes 63 (34.8) 154 (33.6) 184 (34.3) 218 (31.3) 0.62
Prior myocardial infarction 84 (46.4) 225 (49.1) 277 (51.7) 338 (48.4) 0.56
Prior percutaneous coronary interventions 90 (49.7) 245 (53.5) 339 (63.2) 359 (51.4) < 0.001
Prior coronary artery bypass grafting 31 (17.1) 66 (14.4) 84 (15.7) 88 (12.6) 0.3
Prior cerebral stroke 10 (5.5) 21 (4.6) 20 (3.7) 30 (4.3) 0.76
Kidney failure 25 (13.8) 56 (12.2) 54 (10.1) 81 (11.6) 0.48
Hypertension 149 (82.3) 355 (77.5) 419 (78.2) 515 (73.8) 0.06
Chronic obstructive pulmonary disease – 12 (2.62) 18 (3.3) 18 (2.57) 0.67
Smoking 34 (18.8) 57 (12.4) 83 (15.5) 104 (14.9) 0.21
Clinical presentation before PCI:
Stable angina 92 (50.8) 185 (41) 360 (67.4) 441 (63.3) < 0.001
Unstable angina 62 (34.2) 71 (15.7) 123 (23) 177 (25.4) < 0.001
NSTEMI 17 (9.4) 69 (15.3) 43 (8) 62 (8.9) < 0.001
STEMI 10 (5.5) 126 (27.9) 8 (1.5) 16 (2.3)  < 0.001
Vascular access:
Femoral 95 (52.5) 214 (46.7) 199 (37.1) 64 (25.9) < 0.001
Radial left 19 (10.5) 42 (9.2) 59 (11) 22 (8.9) 0.72
Radial right 66 (36.5) 200 (43.7) 274 (51.1) 160 (64.8) < 0.001
Other 1 (0.5) 2 (0.4) 4 (0.7) 1 (0.4) 0.9
Angiographic image:
Single vessel disease 64 (35.3) 65 (34.9) 74 (38.5) 85 (34.4) 0.82
MVD without LMCA involvement 92 (50.8) 89 (47.8) 88 (45.8) 121 (49) 0.8
MVD with LMCA involvement 24 (13.2) 30 (17.2) 29 (15.1) 41 (16.6) 0.8
Separate LMCA involvement 1 (0.5) 2 (1.1) 1 (0.5) 0 (0) 0.83
LMCA – left main coronary artery, MVD – multivessel disease, NSTEMI – non ST-segment elevation myocardial infarction, STEMI – ST-segment elevation myocardial 
infarction. 
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with unstable angina (34.2% vs. 25.4%, p < 0.001), non-
ST segment elevation myocardial infarction (9.4% vs. 
8.9%, p < 0.001) and ST segment elevation myocardial 
infarction (5.5% vs. 2.3%, p < 0.001) tended to decrease 
significantly. Similarly as in the general population of pa-
tients treated with PCI, those with additional RA usage 
were significantly more often treated from right radial 
access in 2017 (64.8%) compared to 2014 (36.5%, p < 
0.001), while femoral access was rare (52.5% vs. 25.9%, 
p < 0.001). The angiographic image of patients qualified 
for PCI with RA did not change significantly in successive 
years (from 2014 to 2017), but a slight trend was not-
ed regarding the increase in the percentage of patients 
with multivessel disease and left-main coronary artery 
involvement (from 13.2% in 2014 to 16.6% in 2017). This 
is presented in Table II. 
Procedural-related variables and culprit lesion 
characteristics
In successive years (from 2014 to 2017), over 98% 
of patients were treated with PCI and RA due to de-novo 
lesions. There were no patients with in-stent thrombo-
sis. The rate of restenosis was comparable in successive 
years and ranged from 1.2% to 1.9%. The mean contrast 
volume (244.4 ±111.9 ml vs. 208.9 ±96 ml, p = 0.0004) 
and radiation dose (2.36 ±1.58 Gy vs. 1.5 ±1.2 Gy, p < 
0.001) significantly decreased in successive years from 
2014 to 2017. Drug-eluting stents were implanted sig-
nificantly more often in 2017 compared to 2014 (96.9% 
vs. 99.7%, p < 0.001), contrary to bare-metal stents, 
which were significantly less often used in 2017 (1.5% 
vs. 0.2%). Also, the frequency of intravascular ultrasound 
increased significantly in successive years from 3.9% in 
2014 to 6.9% in 2017 (p = 0.01). This is presented in 
Table III. 
Angiographic effectiveness
Angiographic effectiveness expressed as TIMI flow 
grade after PCI with RA did not change significantly in 
successive years. However, the percentage of patients 
with TIMI flow grade 3 was non-significantly lower in 
patients in 2017 compared to 2014 (95.3% vs. 97.1%); 
when combined with TIMI flow 2 (patent target artery) 
after PCI, it reached over 98% each successive year from 
2014 to 2017. It is also worth underlining that in succes-
sive years, from 2014 to 2017, there was a significant 
increase in the number of more advanced lesions, which 
was expressed as an increased rate of patients with TIMI 
1 grade flow before PCI with RA (9.7% vs. 19.7%, p = 
0.005). This was parallel to the non-significant decrease 
of patients with TIMI 2 and 3 grade flow before PCI with 
RA. This is presented in Table III. 
Similarly, after the division of the overall group accord-
ing to the volume of RA performed in particular centers 
(< 20 RA per year <), there were no significant differences 
in procedural effectiveness or in the overall population in 
successive years. This is presented in Table IV. 
Periprocedural complications
The overall complication rate decreased significantly 
from 2014 to 2017 (8.28% vs. 3.29%, p = 0.003); how-
ever, in the last 3 years (2015–2017), it remained stable 
at around 3%. Particular components of the overall com-
plication rate did not change during the analyzed peri-
od, except for procedure-related cerebral stroke, which 
reached 1.65% in 2014, while there were no cerebral 
strokes related to the RA procedure in successive years. 
Similarly, after the division of the overall group ac-
cording to the volume of RA performed in particular 
centers (< 20 RA per year <), there were no significant 
differences in procedure-related complication rates or in 
the overall population in successive years. However, the 
rate of periprocedural complications tended to be higher 
in low-volume centers in successive years and the overall 
population. Besides the fact that the overall complication 
rate tended to be higher in low-volume centers, the rate 
of coronary artery perforations was significantly higher 
in high-volume centers compared to low-volume ones 
(p < 0.05) regarding particular complications in the over-
all group of patients (Table V). 
Discussion
The main finding of the current study is that the rate of 
PCI with RA increased more than three-fold in the last four 
years. This was accompanied by a simultaneous increase 
in the number of catheterization laboratories able to per-
form RA. The number of those centers increased more 
than two-fold. The increase in the number of catheter-
ization laboratories was not accompanied by a decrease 
in the overall number of patients treated at high-volume 
centers with the annual rate of rotablations more than 
10 or 20 procedures per year. It could be concluded that 
the increase in low-volume small centers able to perform 
rotablation was compensated by the parallel increase in 
the number of patients treated at high-volume centers. 
This indicates that the demand for rotational procedures 
in Poland is still greater than their supply, i.e. the current 
number of treatments performed. Based on those trends, 
it could be suspected that the results of rotablations 
would be poorer due to the fact that more patients are 
treated at less experienced centers. To reduce the possi-
bility of such a phenomenon, a number of Proctor cours-
es are held in Poland that maintain the performance of 
RA procedures at a high and acceptable level, despite the 
decentralization of their performance. In addition, a num-
ber of treatments at low-volume centers are performed 
under the supervision of operators from high-volume 
centers to maintain high quality rotablations. All of these 
activities contribute to the fact that both the frequency of 
complications and the effectiveness of the treatments es-
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Table III. Procedural indices, effectiveness of rotational atherectomy expressed as TIMI flow grade before and 
after PCI and procedure-related complications in patients treated with rotational atherectomy in Poland in the 
period 2014–2017
Variable Years P-value
2014 2015 2016 2017
Contrast volume [ml] 244.4 (111.9) 235.8 (120.7) 211.9 (86.5) 208.9 (96) 0.0004
Radiation dose [Gy] 2.36 (1.58) 1.88 (1.33) 1.71 (1.35) 1.5 (1.2) < 0.001
Type of culprit lesion:
De novo 246 (98.4) 607/619 (98.1) 733 (98.6) 1,009 (98.8) 0.64
Restenosis 4/250 (1.6) 12/619 (1.9) 10 (1.3) 12 (1.2) 0.64
In-stent thrombosis 0 (0) 0 (0) 0 (0) 0 (0) –
Type of intervention:
Drug-eluting stent 251 (96.9) 583 (97.2) 707 (99.6) 954 (99.7) < 0.001
Bare-metal stent 4/259 (1.5) 7/600 (1.2)  3/710 (0.4) 2/957 (0.2) 0.02
Bioresorbable scaffold 0 (0) 10/600 (1.7) 0 (0) 1/957 (0.1) < 0.001
Drug-coated balloon 5/181 (2.7) 9/458 (2) 8/536 (1.5) 4/698 (0.6) 0.07
Fractional flow reserve 2 (1.1) 7 (1.5) 2 (0.4) 7 (1) 0.31
Intravascular ultrasound 7 (3.9) 19 (4.1) 16 (3) 48 (6.9) 0.01
Optical coherence tomography 1 (0.55) 9 (2) 0 (0) 3 (0.4) 0.0016
Bifurcation 23/181 (12.7) 44/458 (9.6) 64/536 (11.9) 97/698 (13.9) 0.17
Chronic total occlusion 9/181 (5) 19/458 (4.1) 26/536  (4.8) 26/698 (3.7) 0.75
TIMI grade flow before PCI:
0 14/175 (8) 33/441 (7.5) 39/524 (7.4) 44/676 (6.5) 0.86 
1 17/175 (9.7) 64/441 (14.5) 79/524 (15.1) 133/676 (19.7) 0.005
2 49/175 (28) 110/441 (24.9) 107/524 (20.4) 154/676 (22.8) 0.14
3 95/175 (54.3) 234/441 (53.1) 299/524 (57.1) 345/676 (51) 0.22
TIMI grade flow after PCI:
0 0/176 (0) 2/448 (0.4) 4/527 (0.7) 3/685 (0.4) 0.63
1 1/176 (0.6) 4/448 (0.9) 1/527 (0.2) 4/685 (0.6) 0.52
2 4/176 (2.3) 7/448 (1.6) 11/527 (2.1) 25/685 (3.6) 0.13
3 171/176 (97.1) 435/448 (97.1) 511/527 (97) 653/685 (95.3) 0.29
Procedure-related complications:
All complications 15 (8.28) 12 (2.62) 16 (2.98) 23 (3.29) 0.003
Coronary artery perforation 3 (1.65) 4 (0.87) 5 (0.93) 6 (0.85) 0.79
Death 1 (0.55) 0 (0) 0 (0) 1 (0.14) 0.2
Cerebral stroke 3 (1.65) 0 (0) 0 (0) 0 (0) 0.01
No-reflow phenomenon 2 (1.1) 2 (0.43) 4 (0.74) 2 (0.28) 0.48
Myocardial infarction 1 (0.55) 0 (0) 1 (0.18) 3 (0.42) 0.45
Arterial dissection 1 (0.55) 1 (0.53) 0 (0) 1 (0.4) 0.79
Cardiac arrest 3 (1.65) 4 (0.87) 2 (0.37) 6 (0.85) 0.39
Bleeding 0 (0) 1 (0.21) 2 (0.37) 3 (0.42) 0.79
Allergic reaction 0 (0) 0 (0) 2 (0.37) 1 (0.14) 0.46
PCI – percutaneous coronary intervention, TIMI – thrombolysis in myocardial infarction.
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Table IV. Effectiveness of rotational atherectomy expressed as TIMI flow grade before and after PCI in Poland 




Number of RA procedures performed per year per catheterization laboratory 
2014 2015 2016 2017 2014–2017
< 20 > 20 < 20 > 20 < 20 > 20 < 20 > 20 < 20 > 20
Before PCI:
0 6 (7.2) 8 (8.7) 19 (9.4) 14 (5.8) 22 (6.4) 17 (9.3) 28 (7.5) 16 (4.9) 75 (7.5) 55 (6.7)
1 7 (8.4) 10 (10.9) 30 (14.8) 34 (14.2) 63 (18.4) 16 (8.8)* 78 (21) 55 (18) 178 (17.8) 115 (14)*
2 27 (32.5) 22 (23.9) 49 (22.1) 61 (25.2) 62 (18.1) 45 (24.7) 82 (22.1) 72 (23.6) 220 (22) 200 (24.4)
3 43 (51.8) 52 (56.5) 104 (51.5) 130 (55.2) 195 (57) 104 (57.1) 183 (49.3) 162 (53.1) 525 (52.6) 448 (54.8)
After PCI:
0 0 (0) 0 (0) 1 (0.5) 1 (0.4) 1 (0.3) 3 (1.6) 2 (0.5) 1 (0.3) 4 (0.4) 5 (0.6)
1 1 (1.2) 0 (0) 1 (0.5) 3 (1.2) 1 (0.3) 0 (0) 2 (0.5) 2 (0.6) 5 (0.5) 5 (0.6)
2 3 (3.6) 1 (1.1) 5 (2.5) 2 (0.8) 9 (2.6) 2 (1.1) 14 (3.8) 11 (3.5) 31 (3.1) 16 (1.9)
3 80 (95.2) 91 (98.9) 194 (96.5) 241 (97.6) 334 (96.8) 177 (97.2) 352 (95.1) 301 (95.5) 960 (96) 810 (96.9)
*p < 0.05 comparing the difference between centers with > and < than 20 RA procedures per year; PCI – percutaneous coronary intervention, RA – rotational atherec-
tomy, TIMI – thrombolysis in myocardial infarction.
Table V. Procedure-related complications in patients treated with rotational atherectomy in Poland during 
2014–2017 according to the number of RA procedures performed annually
Variable Number of RA procedures performed per year per catheterization laboratory 
2014 2015 2016 2017 2014–2017
< 20 > 20 < 20 > 20 < 20 > 20 < 20 > 20 < 20 > 20
All complications 8 (9.1) 7 (7.5) 5 (2.4) 7 (2.8) 11 (3.1) 5 (2.7) 14 (3.8) 9 (2.7) 38 (3.7) 28 (3.3)
CAP 0 (0) 3 (3.2) 1 (0.5) 3 (1.2) 2 (0.6) 3 (1.6) 2 (0.5) 4 (1.2) 5 (0.5) 13 (1.5)*
Death 1 (1.1) 1 (1) 0 (0) 0 (0) 0 (0) 0 (0) 1 (0.3) 0 (0) 2 (0.2) 1 (0.1)
Cerebral stroke 3 (3.4) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 3 (0.8) 0 (0)
No-reflow 1 (1.1) 1 (1.1) 2 (0.9) 0 (0) 3 (0.8) 1 (0.5) 1 (0.3) 1 (0.3) 7 (0.7) 3 (0.3)
MI 1 (1.1) 0 (0) 0 (0) 0 (0) 1 (0.3) 0 (0) 1 (0.3) 2 (0.6) 3 (0.3) 2 (0.2)
Arterial dissection 1 (1.1) 0 (0) 1 (1.6) 0 (0) 0 (0) 0 (0) 1 (0.9) 0 (0) 3 (0.8) 0 (0)
Cardiac arrest 1 (1.1) 2 (2.1) 1 (0.5) 3 (1.2) 1 (0.3) 1 (0.5) 5 (1.3) 1 (0.3) 8 (0.8) 7 (0.82)
Bleeding 0 (0) 0 (0) 0 (0) 1 (0.4) 2 (0.6) 0 (0) 2 (0.5) 1 (0.3) 4 (0.4) 2 (0.2)
Allergic reaction 0 (0) 0 (0) 0 (0) 0 (0) 2 (0.6) 0 (0) 1 (0.3) 0 (0) 3 (0.3) 0 (0)
*P < 0.05 comparing the difference between centers with > and < than 20 RA procedures per year. CAP – coronary artery perforation, MI – myocardial infarction, 
RA – rotational atherectomy. 
timated as the patency of the vessel after the procedure 
are maintained at a stable level. 
Based on the current analysis, patients qualified for 
PCI with RA presented more complicated lesions includ-
ing left-main coronary artery involvement in multi-vessel 
disease in successive years, but on the other hand, there 
were more patients with stable angina before the proce-
dure in more recent years. Thus, it may be concluded that 
preparation for the procedure was better. 
However, a number of recently published papers en-
courage operators to use rotablation more frequently in 
acute coronary syndromes [9]. The procedure effective-
ness assessed as target artery patency did not decrease 
in the most recent years, even though target arteries 
had poorer TIMI grade flow before the procedure in re-
cent years. While the dissemination and progression of 
coronary artery atherosclerosis of patients qualified for 
PCI with RA tended to be greater, the rate of concom-
Rafał Januszek et al. Trends in the use of rotational atherectomy in Poland 
165Advances in Interventional Cardiology 2019; 15, 2 (56)
itant diseases and the mean age tended to decrease. 
This could suggest that among sick patients, those less 
ill have been treated in the most recent years within the 
aspect of the general clinical state, while concerning cor-
onary atherosclerosis, patients treated with RA tend to 
present more advanced coronary atherosclerosis. More-
over, it has to be mentioned that remaining in line with 
current trends, femoral, instead of radial access, has be-
come a minority. This was also indicated in one of the 
previously published papers analyzing Polish patients 
treated with RA and other reports [10, 11] was and was 
also not reflected in the increased rate of procedure-re-
lated complications, which was stable in the last 3 years 
of the present analysis and was around 3%. It should be 
noted that most of the previously published registers 
concerned significantly smaller groups of patients, and 
their analysis included complications from the entire 
hospitalization period and not only from the stay in the 
catheterization room. That is why their percentages were 
higher compared to our study [12, 13]. However, one may 
have reservations about the low frequency and underes-
timation of the number of procedure-related complica-
tions, but in the case of analysis among large groups of 
patients, it is assumed that certain trends do not change 
significantly and reflect real life [14]. 
Limitations
This study was based on a nationwide volunteer reg-
istry rather than a prospective randomized clinical trial. 
This tends to decrease and underestimate the detection 
of periprocedural complication rates and other crucial 
variables which are dependent on subjective assessment 
of the operator, despite the large overall interventional 
volume included in our analysis. Also, the assessment of 
blood flow in the target artery using the TIMI scale is sub-
jective and depends on individual operators, despite the 
fact that a large number of procedures can significantly 
reduce this effect. Furthermore, the current analysis does 
not include all in-hospital complications, which certainly 
weakens its value. The low percentage of myocardial in-
farctions is particularly noteworthy. Nonetheless, the ad-
vantage of the current study is that the results are closer 
to real life than to randomized clinical trials and show 
clinical data depicting the results of rotational atherec-
tomy in Poland as one of the leaders in Central Europe. 
Conclusions
The current trends and procedural outcomes of PCI 
with RA are promising. The substantial increase in the 
number of low-volume centers and patients treated at 
them is compensated by the increase in the number of 
patients at high-volume centers. Continuous substantive 
supervision and permanent training contribute to main-
taining a high level of rotablation. Those fluctuations in 
the location of RA treatment are not related to poorer pro-
cedural outcomes or an increased rate of procedure-re-
lated complications. Shortening the time of surgery, the 
greater frequency of radial access and reducing the dose 
of contrast also contribute to lessening the percentage of 
procedure-related complications. Such a rapid increase in 
the number of treatments and centers performing them 
indicate very high market demand for rotablation.
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